ATCC 2023 Holiday Shipping Schedule: We will be closed from December 22nd to January 1st. To ensure timely delivery, please submit orders in accordance with the following: Domestic orders no later than December 15th for shipment by December 20th 2023; International orders no later than December 12th for shipment by the first week of January 2024. We will resume our normal shipping schedule on January 2nd, 2024. Thank you for your cooperation. 

  • Quick Order
  • Careers
  • Support

Development and Verification of Synthetic RNA Controls for Determination of Influenza Virus Load

Round, iridescent, green-blue  H1N1 (swine flu) virus with protrusions.

ASM 2014

Boston, Massachusetts, United States

May 01, 2014


Influenza is one of the most significant causes of acute respiratory infection worldwide. Rapid diagnostic tests for highly contagious pathogens, such as Influenza, are essential for decreasing the public health impact of emerging infectious diseases and bioterrorism agents. However, these tests require positive controls that are not always readily available. Consequently, if worldwide public health laboratories are unable to meet the costly regulations required for the import, transfer, and safe use of pathogens used as controls, then critical diagnostic, surveillance, and epidemiological information could be missed.

The use of in vitro synthesized viral RNA as a control would provide essential equivalency standards that would be accessible to any laboratory performing quantitative RT-PCR tests. Synthetic RNA controls are particularly useful for laboratories that lack appropriate biosafety containment facilities for propagating a particular pathogenic virus or have difficulty gaining access to the organism in question due to international tightening of both import and export controls.

Download the poster to explore the development and verification of synthetic RNA controls for influenza virus.